throbber
DRUGS AND THE PHARMACEUTICAL SCIENCES
`
`M0780} [siee)
`
`Nasal Systemic
`ea
`
`AQUESTIVE EXHIBIT 1082 Page 0001
`
`Yie W. Chien
`Kenneth S.E. Su
`SNe mclO Oxia 014
`
`AQUESTIVE EXHIBIT 1082 Page 0001
`
`

`

`
`Nasal Systemic
`j
`Drug Delivery
`|
`
`
`
`
`
`
`
`YIE W. CHIEN
`Controlled Drug-Delivery Research Center
`College of Pharmacy, Rutgers University
`Piscataway, New Jersey
`
`KENNETHS. E. SU
`Pharmaceutical Research Department
`Eli Lilly and Company
`Indianapolis, Indiana
`
`
`
`7
`
`.
`
`SHYI-FEU CHANG
`Department of Pharmaceutics/Drug Delivery
`Amgen Incorporated
`Thousand Oaks, California
`
`d
`
` AQUESTIVE EXHIBIT 1082 Page 0002
`
`
`MARCELDEKKER, INC.
`
`New York « Basel
`
`AQUESTIVE EXHIBIT 1082 Page 0002
`
`

`

` Library of Congress Cataloging-in-Publication Data
`
`Nasal systemic drug delivery / [edited by] Yie W. Chien, Kenneth S. E.
`Su, Shyi-Feu Chang.
`p.
`cm. ~(Drugs and the pharmaceutical sciences; v. 39)
`Includesbibliographies and index.
`ISBN 0-8247-8093-0 (alk. paper)
`1. Intranasal medication.
`I. Chien, Yie W.
`Kenneth S. E.
`II. Chang, Shyi-Feu
`RM160.N37
`615’.6--dc20
`
`Il. Su,
`IV. Series.
`
`89-12007
`CIP
`
`1989
`
`'
`
`
`
`
`This bookis printed on acid-free paper.
`
`Copyright © 1989 by MARCEL DEKKER, INC.
`
`All Rights Reserved
`
`Neither this book nor any part may be reproduced or transmitted in any form
`or by any means, electronic or mechanical, including photocopying, micro-
`filming, and recording, or by any information storage andretrieval system,
`without permission in writing from the publisher.
`
`MARCEL DEKKER, INC.
`270 Madison Avenue, New York, New York 10016
`
`Currentprinting (last digit).
`
`
`
`
`
`
`
`
`10987654321 PRINTED IN THE UNITED STATES OF AMERICA
`
`AQUESTIVE EXHIBIT 1082 Page 0003
`AQUESTIVE EXHIBIT 1082 Page 0003
`
`

`

` 4
`
`
`Anatomyand Physiology of the Nose
`
`The bioavailability of a drug and hence its therapeutic effectiveness are often
`influenced by the route selected for administration. For a medication to
`achieve its maximal efficacy, a drug should be able to be administered easily
`so better patient compliance can be achieved; andit should be capable of
`being absorbedefficiently so greater bioavailability can be accomplished. The
`nasal route appears to be an ideal alternative to the parenterals for adminis-
`tering drugs intended for systemic effect in view of the rich vascularity of
`the nasal membranes and the ease of intranasal administration.
`Several advantages can be achieved from delivering drugsintranasally:
`(a) avoidance of hepatic “first-pass” elimination, gut wall metabolism, and/or
`destruction in gastrointestinal tracts; (b) the rate and extent of absorption
`and the plasma concentration vs. time profile are relatively comparable to
`that obtained by intravenous medication; and (c) the existence of a rich vas-
`culature and a highly permeable structure in the nasal membranes for absorp-
`tion. These advantages have made the nasal mucosa a feasible and desirable
`site for systemic drug delivery.
`.
`However, there are somefactors that should also be considered for opti-
`mizing the intranasal adminstration of drugs: (a) methods and techniques of
`administration; (b) thesite of disposition; (c) the rate of clearance; and (d)
`the existence of any pathological conditions which may affect the nasal
`functions. These factors could potentially influence the efficiency of nasal
`absorption ofdrugs.
`
`
`
` AQUESTIVE EXHIBIT 1082 Page 0004
`
`AQUESTIVE EXHIBIT 1082 Page 0004
`
`
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`To study the intranasal delivery of drugs for systemic medication,it is im-
`portantto first gain some fundamental understanding of the anatomy and
`physiology of the nose.
`
`1.1. NASAL PASSAGE
`
`The upperrespiratory tract is constantly influenced by the inspiredair.
`The nasal modification of the inspired air by filtration, humidification, and/
`or warming are considered to be prime functions of the nose in man (1). To
`carry out its functions, the nose must control the rate of air flow, remove
`noxious agents, and introduce large quantities of fluid into the air stream.
`The nasal passage which runs from thenasal vestibule(i.e., nasal valve)
`to the nasopharynx has a depth of approximately 12-14 cm (2) (Figure 1.1).
`In this passage, the nasal cellular apparatus is in close contact with mucus
`which protects the mucosa from the inspired air. There are three distinct
`functional zones in the nasal cavities (3,4); namely, vestibular, respiratory,
`and olfactory areas, which are arranged anteroposteriorly in this sequence
`of order (Figure 1.2). (a) The vestibular area serves as a baffle system, and
`its surface is covered by a common pseudostratified epithelium where the
`long hairs may provide the functionoffiltering airborneparticles. (b) The
`respiratory area has a surface lined by a pseudostratified columnar epithel-
`ium, and is normally covered by a dense layer of mucusthatis constantly
`moving toward the posterior apertures of the nasal cavity by a powerful
`system of motile cilia. (c) The olfactory region is about 10 cm?, as com-
`pared to 170 cm? in the German shepherd dog. Theolfactory airwaylies
`above the middle turbinate between the nasal septum andthelateral wall
`of the main nasal passage. The airway here is only about 1-2 mm wide and
`is contiguousto the cribriform plate above. This region is generally free of
`inspiratory air flow.
`The nasal passage is composedof a horizontally skin-lined vestibule with
`the passages being directed upward and backward, andis separated by a car-
`tilaginous, bony nasal septum (5). The lateral wall is convoluted with stra-
`tegically placed turbinates that mold the air stream to their configurations
`and changing dimensions.
`The anterior nares mark the beginning of the double nasal airway, which
`extends from the entranceat the nostrils to the beginning ofciliated mucosa
`
` CHAPTER 1
`
`
`
`
`
`at the anterior ends of the nasal septum andturbinates (5,6). The main AQUESTIVE EXHIBIT 1082
`
`AQUESTIVE EXHIBIT 1082 Page 0005
`Page 0005
`
`
`

`

` ANATOMY AND PHYSIOLOGY OF THE NOSE
`
` +t
`
`(Left) The upper airways seen from the midline. The dashed line
`Figure 1.1
`just beyondthe nostril marks the beginning of the nasal valve, whereas the
`dotted line shows approximately the beginning of the ciliated epithelium re-
`gion. The dashed line near the nasopharynx indicates the posterior termina-
`tion of the nasal septum. (Right) Section through the main nasal passage
`showing the nasal septum, folds of the turbinates, and airway. The stippled
`area indicates the olfactory region, which is generally free of inspriatory air
`flow. The hatched areas mark the meatal spaces, through which there is very
`little air flow, but in which there exist the communications with the paranasal
`sinuses and nasolacrimal duct. The clear areas represent the main nasalair-
`way for inspiratory airflow and the region lined with richly vascular erectile
`tissue. This is the site primarily reached by the medications applied intra-
`nasally as nose dropsor fine aerosol sprays. (From Ref. 1, reproduced with
`permission of Elsevier.)
`
`Ei
`
`AS
`
`:pFetee
`
`nasal passage extends backward by approximately 6-8 cm to the posterior
`ends ofthe turbinates and the arch of the septum.
`Its crosssectionis large,
`but the width of the convoluted air stream is narrow. The liningis ciliated,
`highly vascular, and rich in mucous glands and gobletcells. The septum
`ends at the nasopharynx and the airways merge into one (7).
`
`
`
`
`AQUESTIVE EXHIBIT 1082 Page 0006
`AQUESTIVE EXHIBIT 1082
`Page 0006
`
`

`

`4
`
`CHAPTER 1
`
`Figure 1.2 Diagram showingthelateral wall of the nasal cavity. A, nasal
`vestibule, B, internal ostium, C, inferior turbinate; D, middle turbinate, E,
`superior turbinate. The hatchedareas indicate the olfactory region. (From
`Ref. 3, reproduced with permission of Elsevier.)
`
`1.2 NASAL EPITHELIUM
`
`The nasal membrane can beclassified into olfactory and nonolfactory epi-
`thelia (5). The olfactory epithelium is a pseudostratified columnain type,
`and consists of specialized olfactory cells, supporting cells, and both serous
`and mucousglands, whereas the nonolfactory epithelium is a highly vascular
`tissue covered by a ciliated pseudostratified columnar epithelium (Figure
`1.3). The olfactory cells are bipolar neurons andact as peripheral receptors
`and first-order ganglion cells.
`There are two types of mucuscovering the surface of the mucous mem-
`
`Pseggott
`
`
`
`brane: one adheresto thetips ofcilia, and the otherfills the space among the
`
`AQUESTIVE EXHIBIT 1082 Page 0007
`AQUESTIVE EXHIBIT 1082 Page 0007
`
`

`

` ANATOMY AND PHYSIOLOGY OF THE NOSE
`
`
`Figure 1.3. Transmission electron microscopic view of variouscell types in
`the nasal epithelium.
`I, nonciliated columnarcell with microvilli, II, goblet
`cell with mucousgranules and Golgi apparatus,III, basal cell, IV,ciliated
`columnar cell with mitochondria in the apical part, DM, double membrane,
`CTM,connective tissue membrane. (From Ref. 125, reproduced with permis-
`sion of Blackwell.)
`
`
`
`
`cilia. Numerousgroupsof microvilli can be seen microscopically among the
`groups ofcilia. All microvilli are of short clublike appearance andthere are
`approximately 500 microvilli on the surface of each ciliated cell. These cells
`
`with microvilli are called goblet cell. Another type of epithelial cell is ob-
`served in the free surface of the mucous membrane. They are rounded or
`elonged in shape and rough on the surface. These cells are defined as squa-
`
`mouscells. However, some polygonalor elonged cells apparently have
`
` Page 0008
`AQUESTIVE EXHIBIT 1082 Page 0008
`AQUESTIVE EXHIBIT 1082
`
`I
`
`il
`
`il
`
`IV
`
`

`

`
`
`6
`
`CHAPTER 1
`
`numerous microvillilike processes on their outer surface. These basal cells of
`the lining epithelium havea looser intercellular connection and a wider inter-
`cellular space than in the ciliated cells. Furthermore, the subepithelial layer
`is seen to be packed with fibrils and covered with a homogeneous gelatinlike
`substance. Theindividual fine fibrils form bundles, but they are separated
`from each other with branches connecting the adjacentfibril to form net-
`works.
`Adequate moisture is required to maintain the normal functions of the
`nasal mucosa (8). Dehydration of the mucousblanketincreases the viscosity
`of the secretions and reducestheciliary activity. Thus, the recovery of heat
`and moisture from the expired air by the nasal membranesis of fundamental
`importancefor retaining its normal functions.
`In many animal species, including man, pronounced respiratory and car-
`diovascular responses associated with primary reflex from the nose can be
`elicited by appropriate stimulation of the nasal mucous membrane(9).
`Histamine has been detected in the nasal mucosa andalso in the nasal secre-
`tions ofallergic rhinitis (10). Another smooth muscle-stimulating substance,
`probably an unsaturatedacid, has also been found in the nasal mucosa of
`the dog and sheep.
`
`1.3 NASAL SECRETIONS
`
`The composition of nasal secretions is complex and consists of a mixture
`of secretory materials from the gobletcells, nasal glands, and lacrimal glands
`and a transudate from plasma(11,12).
`Ina clean, noninfected, nonallergic, and nonirritated nose, the mucosa is
`covered by a thin layer of clear mucuswhichis secreted from the mucousand
`serous glands in the nasal mucosa and submucosa (13). This mucous blanket
`is moved posteriorly by theciliary beat at a rate of about 1 cm/min, so that
`the nasal mucusis renewed approximately every 10 min. A total of approxi-
`mately 1500-2000 ml of mucus is produced daily, which contains 90-95%
`water, 1-2% salt, and 2-3% mucin. The mucushas a two-layer composition:
`The watery (sol) layer is located immediately adjacent to the mucosalsur-
`face, and the mucous(gel) layer, which is more superficial. Normal nasal
`secretions contain about 150 mEq/L of sodium, 40 mEq/L of potassium,
`and 8 mEq/Lofcalcium aswell as about 600 mg% of proteins,including 57
`mg% of albumins and 133 and 50 mg% of immunoglobulins A (IgA) and G
`(IgG), respectively (14).
`In addition to mucousglycoproteins, nasal secretions contain a variety
`of other proteins:
`lysozymes (15,16), enzymes (17), IgA, IgE, IgG, and al-
`
`
`
`AQUESTIVE EXHIBIT 1082 Page 0009
`AQUESTIVE EXHIBIT 1082 Page 0009
`
`

`

` ANATOMY AND PHYSIOLOGY OF THE NOSE
`
`
`
`aeiS
`
`Mrs
`
`
`
`
`
`
`
`bumins (14-18); kallikrein-like substance (19), protease inhibitor (20,21),
`prostaglandins (22-24), reagenic and antibacterial antibody (25), influenza
`virus-neutralizing activity, and hemagglutination-inhibiting activity (16,26)
`as well as serum proteinslike gamma A-globulin, gamma G-globulin, albumin,
`and siderophilin (27,28).
`The functions of mucusinclude:
`(a) acts as a retainer for the substances
`in the nasal duct; (b) behaves as an adhesive; (c) has water-holding capacity;
`(d) transports particulate matter; (e) exhibits surface electrical activity; (f)
`protects the mucosa; (g) acts as a mesh with permeability; and (h) allows
`heat transfer (13). Both experimentally and clinically, it has been reported
`that the nasal epithelium maybealtered to produce excess mucusbydif-
`ferent agents, including gases,viruses, bacteria, and certain diseases, such as
`allergic rhinitis (11). In addition, parasympathetic stimulation from metha-
`cholin, histamine, or SRS-A (slow-reacting substance of anaphylaxis) will
`also stimulate the secretion of mucous glycoproteins.
`
`1.4 NASAL MUCOCILIARY CLEARANCE
`Nasal ciliary clearance is one of the most important physiological defense
`mechanismsofthe respiratory tract to protect the body against any noxious
`materials inhaled. There are approximately five ciliated cells for each mucous
`cell, with an average of 200cilia extending from every ciliated cell on the sur-
`face of psuedostratified columnar epithelium. An individual cilium is approx-
`imately 5 yw in length and 0.2 p in diameter (29), which moves at a frequency
`of about 20 beats/sec (30). Thefine structure of the cilum consists of a
`ring of nine outer doublets surrounding a central pair (31) (Figure 1.4).
`Each doublet contains an A and B subfibril with both an inner and an outer
`dynein (a complex protein with adenosine triphosphatase [ATPase] activ-
`ity) arm located on the A subfibril with a radial spoke extending toward the
`central doublet. The microtubules are surrounded by a cell membrane which
`is an extension from the body ofthe respiratory epithelial cell. Cilia beat in
`a synchronized fashion in a highly complicated manner. The motion of the
`cilia is dependent upon the microtubules sliding past one another with the
`dynein providing the needed ATPase activity. The bending oftheciliais
`thought to be caused by the radial spokes detaching and reattaching onto
`the central microtubules (32). Their coordination may be associated with
`neutral innervation, chemical pacemakingstimulation from hormones (e.g.,
`epinephrine, serotonin), and the effects of ions (e.g., calcium, potassium)
`(33).
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` Page 0010
`
`AQUESTIVE EXHIBIT 1082
`AQUESTIVE EXHIBIT 1082 Page 0010
`
`
`

`

`
`
`
`CHAPTER 1
`
`SUBFIBER A
`
`
`
`Le CILIARY MEMBRANE
`
`SUBFIBER B
`
`AXONEME
`
`CENTRAL
`MICROTUBULE
`
`DOUBLET
`MICROTUBULE
`
`RADIAL SPOKE
`
`
`
`
`CENTRAL SHEATH
`
`INTERDOUBLET LINK
`
`SPOKE HEAD
`
`Figure 1.4 Diagram of cilium cross section, viewed from base toward tip. A
`ring of nine doublet microtubules surrounds two single central microtubules.
`Each doublet microtubule has two subfibers, A and B: Dynein armsproject
`from subfiber A toward the next microtubule’s subfiber B. (From Ref. 126,
`reproduced with permission of Sci, Am.)
`
`In general nasal mucociliary clearance carries the airway secretions back-
`ward to the nasopharynx (34). This material is dispatched by a wiping action
`of the palate to the stomach periodically through swallowing. However, there
`is an area in the anterior nares of the inferior turbinate from which muco-
`ciliary clearance moves material forward, andthis provides a clearance of de-
`posited foreign materials from the body by nose blowing and wiping (35).
`Nasal clearance proceedsat an average rate of about 5-6 mm/min (36-39).
`The nasal mucociliary function can be impaired by certain air pollutants,
`
`
`
`but not be relative humidity or temperature of the ambientair (36,37 ,40-42). QUESTIVE EXHIBIT 1082 Page 0011
`
`AQUESTIVE EXHIBIT 1082 Page 0011
`
`

`

`ANATOMY AND PHYSIOLOGY OF THE NOSE
`
`
`
`
`i
`ib
`
`is
`ti
`
`In patients with pathological conditions, their mucociliary function may be im-
`paired. Slow mucociliary clearance is associated with nasal polyposis, or an
`injury to the nasal mucosaasa resultofviral infections and other environ-
`mental insults occurring during childhood (37). Drying of the nasal mucous
`membrane will cause the cessation of ciliary activity, whereas prompt moist-
`ening will restore its normalactivity (42). The optimum temperature range
`for mucociliary activity is 28-30°C. Hypotonic saline solutions tend to inhibit
`mucociliary activity, whereas hypertonicsaline solutionswill cause it to stop.
`A highlysignificant correlation between nasal ciliary beat frequency andlog
`MTT(mucustransport time) was recently established in human volunteers,
`The data suggest that nasal ciliary beat frequencyis the main factor in the
`nasal mucociliary clearance in healthy volunteers (43). The transport times,
`as measured by saccharin sodium, ranged from 2.5 to 20.0 min.
`The arrest ofciliary mobility by drugs has been studied. The nasal admin-
`istration of propranolol solution (0.1%) was reportedto arrest the ciliary
`movement of both human adenoids and chicken embryo tracheas within 20
`min (44) (Table 1.1). Cocaine solution yielded an immediate and complete
`paralysis of cilia at 10%, caused the arrest of ciliary activity after 2-3 min
`at 5%, and stoppedciliary activity at 2.5% after 1 h of continuousapplication
`(45). However, a 25% cocaine paste is an effective and safe local anesthetic,
`since sufficient cilia escape direct contact with cocaine crystals, allowing
`the mucous blanketto continue to be swept backward. Lidocaine and
`pontocaine werestudied as to their effect on the mucus clearance ability
`of the humannasal ciliated epithelium (46). Lidocaine at the concentration
`of 4% did not impair mucus flow, whereas 2% pontocaine caused an immedi-
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Table 1.1 The Decreasing Effect of Propranolol on the Ciliary Beat Fre-
`quency of Chicken Embryo Tracheal Epithelium and Human Adenoid
`Epithelium
`
`
`Frequency@ (%)
`Time (min)
`20
`10
`2
`Species
`Concentration
`Compound
`
`Propranolol HCl
`1%
`Chicken
`0
`0
`0.1%
`Chicken
`70
`8
`
`Human 77 250.1% 0
`
`
`
`4Frequency as a percentage of the initial frequency.
`
`
`
`
`
`
`
`
`Source: From Ref. 44, used with permission. AQUESTIVE EXHIBIT 1082 Page 0012
`
`AQUESTIVE EXHIBIT 1082 Page 0012
`
`

`

`
`
`CHAPTER 1
`
`10
`
`ate and complete cessation of bothciliary activity and mucusflow. Xylo-
`metazoline was also reported to diminish the mucociliary transport signifi-
`cantly (47). In another study,the use of xylometazoline at the concentra-
`tion of 1 mg/ml over a 6-week period did not induce any major functional
`and structural changes in normal nasal mucosa (48). In subjects with com-
`moncolds, a prolonged recovery in the mucociliary transport time was ob-
`served during the continued use of nose drops. A very diluted solution of
`adrenocorticotropic hormone (ACTH)esterase inhibitors was foundto accel-
`erate the nasal ciliary movement, whereashigher concentration slowedit
`down (49). Atropine was observed to slow thecilia beat, whereas morphine
`inhibited it. All of these effects are reversible. Tween 20 was reported to
`facilitate the nasal mucociliary clearance in the frog, which may be due to
`the reduction in adhesiveness caused by the surface-active agent(50).
`Normal mucociliary transport is dependent upon the optimal interac-
`tion between the cilia and mucus, which was reportedly influenced by thein-
`gredients in hair spray (51). The depression wassignificantat 15-60 min
`after exposure anddid not regain normal values until 1.5 hr later. The alco-
`hol content of the hair spray mayalso have affected the rheological proper-
`ties of the mucus.
`It has been reported that a gas which rapidly affects ciliary activity at
`low concentration andis relatively resorbed in the nasal cavity will be more
`toxic than a gas which is not resorbedin the nose andhaslittle influence
`on thecilia.
`
`1.5 NASAL BLOOD FLOW
`The blood vessels in the nasal mucosaare of importance in the functions
`of the nose for thermal regulation and humidification of the inhaledair,
`and for controlling the lumen of the nasal passage.
`The nasal mucosais highly vascular. The surface of epithelium is sup-
`plied with a dense network of erectile carvernoustissue, whichis particu-
`larly well developed over the turbinates and septum (52,53). The vascular
`bed provides a rich surface for drug absorption. Constriction of the blood
`vessels would decrease blood flow and blood contentin the nasal mucosa,
`whereas vasodilation would yield the opposite response. The penetration of
`drug through the sinus mucosa is partly influenced by the blood flow in the
`region under normal and pathological conditions.
`The arterial supply to the nose is derived from both the external and the
`internal carotid arteries. The terminal branch of the maxillary artery, which
`
`
`
`AQUESTIVE EXHIBIT 1082 Page 0013
`QUESTIVE EXHIBIT 1082 Page 0013
`
`

`

`ANATOMY AND PHYSIOLOGY OF THE NOSE
`
`
`
`
`
`
`
`
`is a branch of the external carotid, supplies the sphenopalatine artery, which
`in turn supplies blood to the lateral and medial wall of the nasal chamber
`(54). On the other hand, the anterior and posterior ethmoid branches from
`the ophthalmic artery , which is a branch of the internal carotid artery. These
`yessels supply the anterior portion of the nose. The porosity of the endo-
`thelial basement membraneseemstofacilitate the exposure of the contractile
`elementsin the blood wall to agents carried by the blood. The nasal vascular
`bedis so designed that rapid exchange can be made forfluid and dissolved
`substances between the blood vessels and the nasal tissues (55). The capillary
`flow in the nasal mucosa wasreported to be about 0.5 mi/g/min, whereas
`the anteriovenous shunt flow was found to be 60% of the total blood flow in
`the cat. Sympathetic stimulation was reported to producea greater reduction
`in shunt flow than in capillary flow (56).
`Manydifferent factors, both local and general, have been identified to
`affect the vasomotor reaction of the nose. Thelocal factors include the
`changes in the ambient temperature and humidity, the nasal administration
`of vasoactive drugs, the external compressionoflarge veins in the neck,
`trauma, and inflammation (52). The general factors that affect nasal blood
`flow include emotion,fear, frustration, humiliation, anxiety, changes in en-
`vironmental temperature, hyperventilation, and exercise (57,58). Nasal air-
`way resistance wasreportedto increase at rest in the supine position and to
`decrease during exercise owing to some changesin the thickness of nasal
`mucosa as regulated by the capacitance vessels (58). The data suggest that the
`blood flow and the blood content of the human nasal mucosa are not affected
`in the same way by exercise.
`The blood flow in the maxillary sinus mucosa in humanswasreported to
`be in the range of 0.58-1.25 ml/g/min, as measured by microspheres (59-61),
`0.09-0.77 mi/g/min, as measured by the Ry,* Cl technique (62), or 34-44
`ml/min, as measured by '°? Xe technique (63).
`Nasal mucosal blood vessels are surrounded by adrenergic nerves, in which
`alpha-adrenoceptors show a functional predominance. Stimulation of these
`receptors produces a decrease in both blood content and blood flow in the
`nasal mucosa of both animals (64-66) and humans,(67,68).
`The nasal blood flow is very sensitive to a variety of agents applied topi-
`cally or systemically. The drugs that were reported to increase the blood
`flow in humansincluded histamine (63), fenoterol (69,70), isoproterenol
`(71), phenylephrine (72), and albuterol (72). The administration of oxymet-
`azoline (63,73) or clonidine (73) in humans was foundto decrease the nasal.
`blood flow.
`
`
`
`areasernieeeneyraeeanetSeenea
`
`Searatement
`
`AQUESTIVE EXHIBIT 1082 Page 0014
`
`AQUESTIVE EXHIBIT 1082 Page 0014
`
`
`

`

` CHAPTER 1
`
`Table 1.2 Response of the Nasal Airway to Some Vasoactive Agents
`
`
`
` Increased patency Decreased patency
`
`Beta agonists, e€.g.,
`Isoproterenol
`Nylidrin
`
`Alphaantagonists, e.g.,
`Phenoxybenzamine
`Phentolamine
`
`Alpha agonists, e.g.,
`Norepinephrine
`Epinephrine
`Methoxamine
`Phenylephrine
`Serotonin
`Dopamine
`Prostaglandins
`Cocaine
`Antihistamines
`Tyramine
`Vasopressin
`
`Acetylcholine
`Histamine
`Papaverine
`Aminophylline
`Reserpine
`Kt
`
`Source: From Ref. 74, reproduced with permission.
`
`Prostaglandins (PGE, , PGE, , PGA, and PGF, a) are generally considered
`to be vasodilating agents. However, they were observed to induce a constric-
`tion of the nasal blood vessels in the dog (74). While PGE, and PGE, were
`found to be equipotent to epinephrine,their duration of action was observed
`to last more than seven times longer in normal humansubjects (75). A partial
`list of drugs and their general effect on nasal patency is shown in Table 1.2.
`
`1.6 NASAL NERVE SUPPLY
`The nasal blood vessels and glandshave a rich nerve supply both from the
`autonomic system and from the somatic system. The nasal mucous mem-
`brane derivesits sensory supply from the cranial nerve and contains sympa-
`thetic and parasympathetic fibers of the autonomic nervous system (76).
`Figure 1.5 showsthe origin of the autonomic innervation of the nose.
`The autonomic innervation of aboutthree-quarters of the nasal mucous
`membranereaches the nose via the vidian nerve and follows the distribution
`of the second division of the trigeminal nerve to the nose (77,78). The
`vidian nerve may consist of parasympathetic and also sympathetic cholin-
`ergic fibers (78). The capillary vessels (or resistance vessels) receive the
`primary alpha-adrenergic sympathetic fibers (constrictor), but may also
`
`
`
`
`
`AQUESTIVE EXHIBIT 1082 Page 0015
`QUESTIVE EXHIBIT 1082 Page 0015
`
`

`

`
`
`
`GENICULATE
`een
`= = . .
`277 SUPERFICIAL ~s_
`PETROSAL
`NERVE
`dp VIDIAN NERVE
`
`SPHENOPALATINE
`GANGLION
`
`—
`
`.
`
`
`
`
`te
`SUPERIOR
` SALIVATORY 3
`NUCLEUS
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ANATOMY AND PHYSIOLOGY OF THE NOSE
`
`TYMPANIC
`PLEXUS
`—
`
`A>
`
`a!
`pi
`
`4
`
`=
`
`CAROTIO
`PLEXUS
`
`
`
`
`
`
`
`CERVICAL
`SYMPATHETIC
`GANGLION
`
`NASAL
`GLANDS
`
`NASAL
`VESSELS
`
`SYMPATHE T/C
`
`“
`
`:
`
`PARASYMPATHETIC
`
`Figure 1.5 Autonomic nasal innervation. Origin of sympathetic and para-
`sympathetic fibers to the nasal mucosa. (From Ref. 76, reproduced with
`permission of the Ear Nose Throat J.)
`
`receive a small beta-adrenergic innervation (dilators). There is a rich para-
`sympathetic innervation of the glands. Nervous stimulation of the glandular
`cholinoceptorscausesa significant hypersecretion and vasodilation (Figures
`1.6 and 1.7). When the cholinergic nerveis stimulated, the arterioles in the
`conchadilate, permeability through the capillary wall changes, the uptake of
`serum constituents through the basement membranesinto the gland in-
`creases, and secretion is formed and then squeezed outof the nasal gland
`(79). Therefore, the cholinergic innervation is dominant in the functioning
`of the nasal glands, whereas adrenergic innervation is predominantin the
`functioning of the vascular system of the nasal mucosa. Stimulation of the
`vidian nerve in the case for 3 min wasnoted to induce nasalsecretions,
`whereas stimulation for 15 sec produced a vasoconstriction in the nasal
`cavity.
`While the arterioles of the inferior concha are richly endowed with adre-
`nergic nerves, the nasal gland is almost devoid of adrenergic nerve fibers
`(79). Electrical stimulation of the sympathetic nerves, using lower impulse
`
`
`
` Page 0016
`
`AQUESTIVE EXHIBIT 1082 Page 0016
`AQUESTIVE EXHIBIT 1082
`
`

`

`
`
`ORDINARY
`EXOGENOUS
`STIMULATION
`
`CHAPTER 1
`
`
`
`VIP (?)
`
`
`
`w
`YC, VIP?
`
`=|PTERYGO- PTERYGO-
`
`
`BY&PALATINE PALATINE
`
`AGANGLION
`GANGLION
`Z
`od
`me
`+
`>
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`* ". CENTRAL NERVOUSSYSTEM © ..
`

`
`Figure 1.6 Stimulation of sensory nerves, ¢.g., by the unconditioned inhaled
`air, initiates parasympathetic reflexes, which cause significant hypersecretion,
`andslight, transient vasodilation. C, cholinoceptor, VIP, vasoactive intestinal
`polypeptide. (From Ref. 127, reproduced with permission of J. Allergy Clin.
`Immunol.)
`
`AQUESTIVE EXHIBIT 1082 Page 0017
`QUESTIVE EXHIBIT 1082 Page 0017
`
`

`

` ANATOMY AND PHYSIOLOGY OF THE NOSE
`
`
`
`
`STELLATE
`GANGLION
`
`
`
`
` |. |S CENTRAL NERVOUS ‘SYSTEM. >.” <e
`
`
`Figure 1.7 Sympathetic innervation of blood vessels. There is a continuous
`impulse traffic in efferent sympathetic fibers to the blood vessels, keeping
`them partially constricted. Action on alpha-1-adrenoceptors causes marked
`vasoconstriction, and stimulation of beta-2-adrenoceptors causes slight vaso-
`dilation. (From Ref. 127, reproduced with permission of J. Allergy Clin.
`Immunol.)
`
`frequencies, was reported to affect mainly the capacitance vessels (80). At
`minimal effective frequency of 2-5 Hz, the sympathetic activity-induced
`stimulation of vidian nerve was noted to increase nasal secretion and also
`induce vasoconstriction in the nasal cavity (81).
`The adrenergic transmitter, norepinephrine, , was found to be present in the
`typical nasal adrenergic nerve terminals(82). In all studies with mammals,
`the nasal mucosa ofthe inferior concha was observed to be dominated by a
`
`
` AQUESTIVE EXHIBIT 1082 Page 0018
`
`
`
`AQUESTIVE EXHIBIT 1082 Page 0018
`
`

`

`
`
`CHAPTER 1
`
`16
`
`rich adrenergic plexus surrounded by a thin muscle layer of the wide veins
`of the erectile tissue. This adrenergic plexus is considered to be of great
`importancein regulating the blood flow through the nasal mucosa. The
`alpha-1, beta, and muscarinic receptors were reported to be present in human
`mucosa (83). Both isoprenaline andterbutaline, beta-receptor-stimulating
`agents, were found to decrease nasal blood flow resistance and nasal potency;
`ie., dilation of resistance and capacitance vessels (84). However, propranolol,
`a beta-receptor-blocking agent, was noted to reducetheeffect of isoprenaline
`and terbutaline on the resistance vessels. Therefore, it is evident that the
`effects of isoprenaline andterbutaline in the nasal vascular bedofthe cat are
`mediatedvia beta-adrenergic receptors,at least in the resistance vessels (85).
`It has been suggested that vasomotorrhinitis is a result of increased para-
`sympathetic activity in the nasal mucosa (78). Following parasympathetic
`stimulation of the nasal mucosa in the cat, the secretory and vascular re-
`sponses were reportedly blocked by atropine (86,87).
`
`1.7 NASAL ENZYMES
`
`Many enzymesexist in nasal secretions. These are cytochrome P-450-depen-
`dent monooxygenases (88-92); lactate-dehydrogenase (93); oxidoreductases
`(94); hydrolases, acid phosphatase andesterase (95), NAD*-dependentfor-
`maldehyde dehydrogenase and aldehyde dehydrogenase (96); leucine amino-
`peptidase (97); phosphoglucomutase, glucose-6-phosphate dehydrogenase,
`aldolase, lactic dehydrogenase, isocitric dehydrogenase, malic enzymes,
`glutamic oxaloacetic transaminase, glutamic pyruvic transaminase (98);
`NAD?*-dependent 15-hydroxyprostaglandin dehydrogenase (99); carboxyl-
`esterase (100), lysosomal proteinases and their inhibitors (101); B-gluco-
`sidase, a-fucosidase, and w-galactosidase (102); succinic dehydrogenase (103);
`lysozyme (104); and steroid hydroxylases (105).
`Cytochrome P-450-dependent monooxygenase has been reported tocata-
`lyze the metabolism ofdifferent xenobiotics (88-93). It has also been ob-
`served to metabolize many compoundsin the nasal mucosa, suchas nasal
`decongestants, nicotine, and cocaine (89); phenacetin (106); N-nitroso-di-
`ethylamine (107,108); N-nitrosonornicotine (109); nitrosoamine (110);
`aminopyrine (111); and progesterone (112).
`Insulin (zinc-free) was found to be hydrolyzed slowly by leucine amino-
`peptidase (97). The aminoacids, released from zinc-free insulin in the in
`vitro studies, were estimated by ion-exchange chromatography. The results
`are shown in Table 1.3. Prostaglandins of the E series were observed to be
`inactivated by the nasal mucosal 15-hydroxyprostaglandin dehydrogenase
`
`
`
`
`
`AQUESTIVE EXHIBIT 1082 Page 0019
`QUESTIVE EXHIBIT 1082 Page 0019
`
`

`

` ANATOMY AND PHYSIOLOGY OF THE NOSE
`
`
`
`
`
`Fes=P=a
`arnt
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Table 1.3 Amino Acids Released from Insulin By Leucine Aminopeptidase
`
`Moles/Mole
`Moles/Mole
`Moles/Mole
`Amino acid
`insulin Aminoacid insulin
`Amino acid
`insulin
`
`
`1.36
`Ser + AspNH,
`0.99
`His
`0.72
`Phe
`$
`Cys-S-Cy
`1.43
`Leu
`1.63
`Val
`0.0
`Arg
`0.48
`Ala
`0.40
`leu
`
`
`
`Gly
`1.09 4 Glu 1

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket